Arnold Irwin Miller, DO Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 737 West Oak Street, Kissimmee, FL 34741 Phone: 407-933-2775 Fax: 407-933-8406 |
Qamar S Khan, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1300 W Oak St, Kissimmee, FL 34741 Phone: 407-303-4078 Fax: 407-303-4083 |
Adnan Akhtar, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1300 W. Oak Street, Kissimmee, FL 34741 Phone: 407-944-5240 Fax: 407-944-5251 |
Dr. Arnaldo R Quinones, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 353 Cypress Pkwy, Kissimmee, FL 34759 Phone: 844-665-4827 |
Jorge Guillermo Otoya, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 737 West Oak Street, Kissimmee, FL 34741 Phone: 407-933-2775 Fax: 407-933-8406 |
Mamta Ved Vijayvargiya, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 737 West Oak Street, Kissimmee, FL 34741 Phone: 407-933-2775 Fax: 407-933-8406 |
News Archive
Epizyme, Inc., a biopharmaceutical company leading the creation of personalized therapeutics to treat patients with genetically defined cancers, today announced the presentation of data evaluating the preclinical safety and efficacy of two of the Company's novel, potent and selective small molecule inhibitors. These inhibitors individually target DOT1L and EZH2, members of a class of epigenic enzymes called histone methyltransferases (HMTs).
The published data provide additional detail of an initial analysis conducted in January, while more robust data from a complete analysis of the study was subsequently shared in March 2021.
The authors of a new study are suggesting that vitamin D may slow down the progression of breast cancer.
Canadians have one of the highest rates of Multiple Sclerosis (MS) in the world with approximately 1,000 new cases diagnosed each year. Primarily striking in adulthood, physicians and researchers with the Canadian Pediatric Demyelinating Diseases Network (CPDDN), a multi-institutional and multidisciplinary group, have found that MS is being increasingly diagnosed in children.
› Verified 9 days ago